{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:14:14Z","timestamp":1791778454515,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1038\/sj.bmt.1705360","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T12:33:26Z","timestamp":1146659606000},"page":"917-922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["High-dose melphalan (200\u2009mg\/m2) supported by autologous stem cell transplantation is safe and effective in elderly (\u2a7e65 years) myeloma patients: comparison with younger patients treated on the same protocol"],"prefix":"10.1038","volume":"37","author":[{"given":"E","family":"Jantunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kuittinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Penttil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Mahlam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Nousiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,3]]},"reference":[{"key":"BF1705360_CR1","first-page":"238","volume":"81","author":"M Clavio","year":"1996","unstructured":"Clavio M, Casciaro S, Gatti AM, Spriano L, Bonanni F, Poggi A et al. Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients. Haematologica 1996; 81: 238\u2013244.","journal-title":"Haematologica"},{"key":"BF1705360_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/bjc.1998.77","volume":"77","author":"A Riccardi","year":"1998","unstructured":"Riccardi A, Mora O, Brugnatelli S, Tinelli C, Spanedda R, De Paoli A et al. Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Br J Cancer 1998; 77: 485\u2013491.","journal-title":"Br J Cancer"},{"key":"BF1705360_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0609.2001.00301.x","volume":"66","author":"P Rodon","year":"2001","unstructured":"Rodon P, Linsassier C, Gauvain JB, Benboubker L, Goupille P, Maigre M et al. Multiple myeloma in elderly patients: presenting features and outcome. Eur J Haematol 2001; 66: 11\u201317.","journal-title":"Eur J Haematol"},{"key":"BF1705360_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 1996; 335: 91\u201397.","journal-title":"N Engl J Med"},{"key":"BF1705360_CR5","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. for Medical Research Council Unit Adult Leukaemia Working Party. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875\u20131883.","journal-title":"N Engl J Med"},{"key":"BF1705360_CR6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V89.3.789","volume":"89","author":"B Barlogie","year":"1997","unstructured":"Barlogie B, Jagannath S, Vesole DH, Naucke S, Cheson B, Mattox S et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789\u2013793.","journal-title":"Blood"},{"key":"BF1705360_CR7","first-page":"7","volume":"95","author":"S Lenhoff","year":"2000","unstructured":"Lenhoff S, Hjorth M, Holmberg E, Turesseon I, Westin J, Nielsen JL et al. for the Nordic Myeloma Study Group. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Blood 2000; 95: 7\u201311.","journal-title":"Blood"},{"key":"BF1705360_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.bmt.1702188","volume":"25","author":"B Sirohi","year":"2000","unstructured":"Sirohi B, Powles R, Treleaven J, Mainwaring P, Kulkarni S, Pandha H et al. The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone Marrow Transplant 2000; 25: 533\u2013539.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1046\/j.1365-2141.2001.02976.x","volume":"114","author":"A Badros","year":"2001","unstructured":"Badros A, Barlogie B, Siegel E, Morris C, Desikan R, Zangari M et al. Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years. Br J Haematol 2001; 114: 600\u2013607.","journal-title":"Br J Haematol"},{"key":"BF1705360_CR10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.bmt.1704288","volume":"32","author":"DE Reece","year":"2003","unstructured":"Reece DE, Bredeson C, Perez WS, Jagannath S, Zhang MJ, Ballen KK et al. Autologous stem cell transplantation in multiple myeloma patients &lt;60 vs \u2a7e60 years of age. Bone Marrow Transplant 2003; 32: 1135\u20131143.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1182\/blood.V99.3.731","volume":"99","author":"P Moreau","year":"2002","unstructured":"Moreau P, Facon T, Attal M, Hulin C, Michallet M, Maloisel F et al. Comparison of 200\u2009mg\/m2 melphalan and 8\u2009Gy total body irradiation plus 140\u2009mg\/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomised trial. Blood 2002; 99: 731\u2013735.","journal-title":"Blood"},{"key":"BF1705360_CR12","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood.V94.4.1248","volume":"94","author":"A Palumbo","year":"1999","unstructured":"Palumbo A, Triolo S, Argentino C, Bringhen S, Dominietto A, Rus C et al. Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients. Blood 1999; 94: 1248\u20131253.","journal-title":"Blood"},{"key":"BF1705360_CR13","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1200\/JCO.1995.13.7.1786","volume":"13","author":"BL Samuels","year":"1995","unstructured":"Samuels BL, Bitran JD . High-dose intravenous melphalan: a review. J Clin Oncol 1995; 13: 1786\u20131799.","journal-title":"J Clin Oncol"},{"key":"BF1705360_CR14","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/sj.bmt.1701763","volume":"23","author":"P Moreau","year":"1999","unstructured":"Moreau P, Milpied N, Mahe B, Juge-Morineau N, Rapp MJ, Bataille R et al. Melphalan 220\u2009mg\/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma. Bone Marrow Transplant 1999; 23: 1003\u20131006.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.bmt.1703840","volume":"31","author":"E Jantunen","year":"2003","unstructured":"Jantunen E, Putkonen M, Nousiainen T, Pelliniemi T-T, Mahlam\u00e4ki E, Remes K . Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma. Bone Marrow Transplant 2003; 31: 347\u2013351.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR16","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1080\/1042819021000015907","volume":"43","author":"E Jantunen","year":"2002","unstructured":"Jantunen E, Kuittinen T, Nousiainen T . A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients. Leuk Lymphoma 2002; 43: 1961\u20131965.","journal-title":"Leuk Lymphoma"},{"key":"BF1705360_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A . Reporting results of cancer treatment. Cancer 1981; 47: 207\u2013214.","journal-title":"Cancer"},{"key":"BF1705360_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blade","year":"1998","unstructured":"Blade J, Samson D, Reece D, Apperley J, Bj\u00f6rkstrand B, Gahrton G et al. for the Myeloma Subcommittee of the EBMT. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Br J Haematol 1998; 102: 1115\u20131123.","journal-title":"Br J Haematol"},{"key":"BF1705360_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V93.1.51","volume":"93","author":"DS Siegel","year":"1999","unstructured":"Siegel DS, Desikan KR, Mehta J, Singhal S, Fassas A, Munshi N et al. Age is not a prognostic variable with autotransplants for multiple myeloma. Blood 1999; 93: 51\u201354.","journal-title":"Blood"},{"key":"BF1705360_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1700833","volume":"20","author":"SC Guba","year":"1997","unstructured":"Guba SC, Vesole DH, Jagannath S, Bracy D, Barlogie B, Tricot G . Peripheral stem cell mobilization and engraftment in patients over 60 years of age. Bone Marrow Transplant 1997; 20: 1\u20133.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1600-0609.2004.00297.x","volume":"73","author":"A Wahlin","year":"2004","unstructured":"Wahlin A, Eriksson M, Hultdin M . Relation between harvest success and outcome after autologous peripheral blood stem cell transplantation in multiple myeloma. Eur J Haematol 2004; 73: 263\u2013268.","journal-title":"Eur J Haematol"},{"key":"BF1705360_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/sj.bmt.1703757","volume":"30","author":"C Thieblemont","year":"2002","unstructured":"Thieblemont C, Dumontet C, Saad H, Roch N, Bouafia F, Amaud P et al. Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma. Bone Marrow Transplant 2002; 30: 769\u2013775.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR23","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/sj.bmt.1704946","volume":"35","author":"A Spencer","year":"2005","unstructured":"Spencer A, Horvath N, Gibson J, Prince HM, Herrmann R, Bashford J et al. Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Bone Marrow Transplant 2005; 35: 971\u2013977.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR24","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1056\/NEJMoa040125","volume":"351","author":"R Spielberger","year":"2004","unstructured":"Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351: 2590\u20132598.","journal-title":"N Engl J Med"},{"key":"BF1705360_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.bmt.1703818","volume":"31","author":"E Terpos","year":"2003","unstructured":"Terpos E, Apperley JF, Samson D, Giles C, Crawley C, Kanfer E et al. Autologous stem cell transplantation in multiple myeloma: improved survival in non-secretory myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single centre experience in 127 patients. Bone Marrow Transplant 2003; 31: 163\u2013170.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bmt.1704728","volume":"35","author":"M Krejci","year":"2005","unstructured":"Krejci M, Buchler T, Hajek R, Svobodnik A, Krivanova A, Pour L et al. Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. Bone Marrow Transplant 2005; 35: 159\u2013164.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.bmt.1705000","volume":"36","author":"B Sirohi","year":"2005","unstructured":"Sirohi B, Powles R, Mehta J, Rudin C, Kulkarni S, Horton C et al. An elective single autograft with high-dose melphalan: single-center analysis of 451 patients. Bone Marrow Transplant 2005; 36: 19\u201324.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705360_CR28","doi-asserted-by":"crossref","unstructured":"Facon T, Mary JY, Hulin C, Benboubker L, Attal M, Renald M et al. Major superiority of melphalan-prednisone (MP)+thalidomide (Thal) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma. Blood 2005; 106 230a (abstract 780).","DOI":"10.1182\/blood.V106.11.780.780"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705360","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:11:46Z","timestamp":1648080706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,5,1]]}},"alternative-id":["BF1705360"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705360","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]},"assertion":[{"value":"29 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}